Delivery Order SPE2DB20D1050-SPE2DB23FH71E
Award Date 4/27/23
Potential Completion Date 4/28/23
Potential Value $3.7K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EPINEPHRINE 0.3 MG AUTO-INJECT 2S. The contract has a potential value of $3,588.72 and a performance period through March 1, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is also the holder of a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $1,138.38 to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Epinephrine 0.3 mg auto-injectors, with a completion date of April 24, 2023. This Delivery Order is issued under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
- The Defense Logistics Agency (DLA) awarded a delivery order contract, valued at $6,591.78, to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, for the supply of EPINEPHRINE 0.3 MG AUTO-INJECT 2S. This contract has a completion date of May 7, 2024. The contract was awarded on May 6, 2024 and is a firm fixed-price, open competition contract with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a significant...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide Epinephrine 0.3 mg auto-inject medication. The $2,081.48 firm-fixed-price contract has a completion date of December 5, 2023 and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for the...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract valued at $9,339.62 to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S, a critical medical product, with a completion date of May 3, 2024. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $1,437.75 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4564085980 EPINEPHRINE 0.3 MG AUTO-INJECT 2S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of EPINEPHRINE 0.3 MG AUTO-INJECT 2S. The fixed-price contract, with a ceiling value of $3,781.02, was awarded on December 15, 2021, with a completion date of December 16, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a $2,859.32 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4563606285 EPINEPHRINE 0.3 MG AUTO-INJECT 2S. This contract, which has a completion date of February 9, 2024, is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, which provides a range of pharmaceutical products and medical supplies to support...
- The Defense Logistics Agency (DLA) awarded a $1,308.86 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EPINEPHRINE 0.3 MG AUTO-INJECT 2S. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025, to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the...
- This federal contract award is for the delivery of EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical supplies to the Defense Logistics Agency (DLA), a defense agency. The $32,921.95 contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., on February 8, 2024, with a completion date of February 9, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB23FH71EDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $3,675.82 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4560743507 - EPINEPHRINE 0.3 MG AUTO-INJECT 2S medical products. The contract has a period of performance through April 28, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This award was made under full and open competition with no set-aside designation.
Generated 5/9/25, 10:01 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 4/27/23 |